RxDoctor Payments Data

Jennifer Mueller, MD

Dermatology · Sinking Spring, PANPI 1972766152

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $67,852 of the $72,801 with a category attached, or 93.2%. AbbVie accounts for 99.1% of it on its own, with 18 other manufacturers making up the rest. Among dermatology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$72,801in general payments, 2019–2025

Across 110 payments — averaging $661.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$72K
  • Johnson & Johnson$131
  • Novartis$90
  • E.r. Squibb & Sons, L.L.C.$79
  • Galderma Laboratories, L.p.$53
  • Dermavant Sciences, Inc.$41
  • plus $257 from 13 others

What the payments were for

  • Speaking & faculty fees$67,85293%
  • Travel & lodging$2,5213%
  • Food & beverage$2,4283%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$72,801 in reported general payments places this provider in the 95th percentile of 626 dermatology providers in Pennsylvania.

See all dermatology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$274,265
Medicare patients
771
Services billed
25,388

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluorouracil33$2,304
Clobetasol Propionate39$1,747
Ciclopirox38$1,470
Clindamycin Phosphate29$1,400
Doxycycline Hyclate48$776
Triamcinolone Acetonide57$647
Metronidazole15$618
Ketoconazole21$598
Fluocinonide11$325
Nystatin28$298
Prednisone13$112
Hydrocortisone21$80

Paid to pharmacies, not to this prescriber.

Other dermatology in Sinking Spring

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →